Product
P-BCMA-ALLO1
1 clinical trial
1 indication
Indication
Multiple MyelomaClinical trial
Open-Label, Multicenter, Phase 1 Study to Assess the Safety of P-BCMA-ALLO1 in Subjects With Relapsed / Refractory Multiple Myeloma (MM)Status: Recruiting, Estimated PCD: 2027-12-01